National Research Corporation (NRC) Appoints Trent Green as CEO

National Research Corporation (NASDAQ: NRC), doing business as NRC Health, a publicly-traded leader in healthcare improvement, is pleased to announce the appointment of Trent Green as its incoming Chief Executive Officer, effective June 1, 2025. Green will succeed Mike Hays, the company’s current CEO, who will transition to the role of Chairman, ensuring a smooth leadership transition while maintaining NRC Health’s mission-driven and shareholder-focused approach.

Green brings more than 25 years of healthcare leadership experience, most recently serving as CEO of One Medical, San Francisco, CA, and previously as Chief Operating Officer at Legacy Health, Portland, OR. His expertise in care delivery, digital transformation, and strategic business execution uniquely positions him to lead NRC Health in expanding its capabilities and strengthening its market presence.

Recognized as a visionary leader in the industry, Green was named to the inaugural list of TIME100 Most Influential People in Health and recently ranked #13 on Modern Healthcare’s Top 100 Healthcare Executives list. These accolades highlight his ability to drive meaningful advancements and transformative change in healthcare.

"Trent’s proven leadership, strategic insight, track record of partnerships, and commitment to healthcare innovation make him the ideal choice to lead NRC Health into the future," said Mike Hays, outgoing CEO and incoming Chairman. "On behalf of the board and our associates, I’m thrilled to welcome Trent to NRC Health."

Green expressed his enthusiasm for the role, stating:
"I am excited to join NRC Health and lead the company during this transformative period. I look forward to working alongside NRC's talented associates to advance innovative solutions that enhance healthcare experiences for patients, providers, and caregivers and drive sustainable growth for our investors."

Under Green’s leadership, NRC Health will build on its 40-year legacy of excellence, innovation, and transparency by advancing personalized, data-driven solutions that enhance experiences and improve outcomes for patients and healthcare professionals.

You May Also Be Interested In

• Trump: we remain committed to a diplomatic resolution to Iran nuclear issue, Iran must give up hopes of nuclear weapons
• Flowco Holdings (FLOC) Announces $50M Share Buyback
• Coherent, Inc. (COHR) releases diamond-loaded SiC ceramic composite for AI data centers